Targeted RFA 2018

Movember Translation Acceleration Grant to Validate Predictive Markers for Treatment Response and Outcome

Prostate Cancer Canada (PCC) invites applications for investigator-initiated Movember Translation Acceleration Grants (TAG).

With more treatments coming on line, there is a greater need to assess who will benefit most from each treatment. Projects funded by this TAG mechanism will validate existing putative markers or tests in patient samples, either retrospectively or within a clinical trial. Assays can be biospecimen or imaging markers or other appropriate tests including histology or bioinformatics.

This request for applications (RFA) solicits proposals from groups developing and validating methods to specifically and accurately predict treatment response and/or patient outcome using an appropriate assay. The end goal is clinical validation of the approach and more accurate and personalized selection of treatments for patients with prostate cancer.

It is expected that a multidisciplinary approach will be required and each Movember TAG application may consist of independent investigators based in multiple institutions. PCC also strongly encourages, wherever possible, that applications would access and use existing banked clinical specimens. PCC will only consider projects that are completely focused on prostate cancer.

This opportunity is awarded by Prostate Cancer Canada and proudly funded by the Movember Foundation.

Award amount: up to $1.5M over 3 years
 smaller-still-(1).jpg
Key dates:
Registration Deadline: May 15, 2018
Full Application Deadline: July 9, 2018
Funding start date: October 1, 2018

Links to:
Online application: https://pccgrants.smartsimple.ca
Program Description
Tipsheet
 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More

Can exercise help slow prostate cancer growth?

Toronto, March 12, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.
More

Prostate Cancer Canada’s Rock the Road Raffle sells out for 5th consecutive year

February 23, 2018 – TORONTO, ON – For the fifth year and counting, Prostate Cancer Canada’s (PCC) Rock the Road Raffle brought together Ontarians from all walks of life to both support an important cause and gain a chance to win a one-of-a-kind dream car.
More


Click here for news archive